vs

Side-by-side financial comparison of Andersons, Inc. (ANDE) and Critical Metals Corp. (CRML). Click either name above to swap in a different company.

Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $359.9K, roughly 915.7× Critical Metals Corp.). Andersons, Inc. runs the higher net margin — 20.5% vs -5262.2%, a 5282.7% gap on every dollar of revenue. Critical Metals Corp. produced more free cash flow last quarter ($-2.6M vs $-77.1M).

The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.

Metlen Energy & Metals is a global industrial and energy company operating two business Sectors: Energy and Metallurgy. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index

ANDE vs CRML — Head-to-Head

Bigger by revenue
ANDE
ANDE
915.7× larger
ANDE
$329.5M
$359.9K
CRML
Higher net margin
ANDE
ANDE
5282.7% more per $
ANDE
20.5%
-5262.2%
CRML
More free cash flow
CRML
CRML
$74.5M more FCF
CRML
$-2.6M
$-77.1M
ANDE

Income Statement — Q4 2025 vs Q4 2024

Metric
ANDE
ANDE
CRML
CRML
Revenue
$329.5M
$359.9K
Net Profit
$67.4M
$-18.9M
Gross Margin
70.3%
Operating Margin
26.6%
Net Margin
20.5%
-5262.2%
Revenue YoY
-2.4%
Net Profit YoY
49.6%
EPS (diluted)
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANDE
ANDE
CRML
CRML
Q4 25
$329.5M
Q3 25
$295.8M
Q2 25
$535.0M
Q1 25
$370.8M
Q4 24
$337.5M
$359.9K
Q3 24
$231.9M
Q2 24
$492.5M
Q1 24
$341.4M
Net Profit
ANDE
ANDE
CRML
CRML
Q4 25
$67.4M
Q3 25
$20.1M
Q2 25
$7.9M
Q1 25
$284.0K
Q4 24
$45.1M
$-18.9M
Q3 24
$27.4M
Q2 24
$36.0M
Q1 24
$5.6M
Gross Margin
ANDE
ANDE
CRML
CRML
Q4 25
70.3%
Q3 25
57.8%
Q2 25
29.6%
Q1 25
41.2%
Q4 24
63.1%
Q3 24
76.4%
Q2 24
35.6%
Q1 24
37.6%
Operating Margin
ANDE
ANDE
CRML
CRML
Q4 25
26.6%
Q3 25
8.7%
Q2 25
4.6%
Q1 25
0.9%
Q4 24
19.9%
Q3 24
26.8%
Q2 24
11.6%
Q1 24
4.1%
Net Margin
ANDE
ANDE
CRML
CRML
Q4 25
20.5%
Q3 25
6.8%
Q2 25
1.5%
Q1 25
0.1%
Q4 24
13.4%
-5262.2%
Q3 24
11.8%
Q2 24
7.3%
Q1 24
1.6%
EPS (diluted)
ANDE
ANDE
CRML
CRML
Q4 25
Q3 25
$0.59
Q2 25
$0.23
Q1 25
$0.01
Q4 24
$1.31
$-0.21
Q3 24
$0.80
Q2 24
$1.05
Q1 24
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANDE
ANDE
CRML
CRML
Cash + ST InvestmentsLiquidity on hand
$98.3M
$149.5K
Total DebtLower is stronger
$560.0M
Stockholders' EquityBook value
$1.2B
$77.1M
Total Assets
$3.7B
$146.3M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANDE
ANDE
CRML
CRML
Q4 25
$98.3M
Q3 25
Q2 25
Q1 25
Q4 24
$561.8M
$149.5K
Q3 24
Q2 24
Q1 24
Total Debt
ANDE
ANDE
CRML
CRML
Q4 25
$560.0M
Q3 25
Q2 25
Q1 25
Q4 24
$608.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ANDE
ANDE
CRML
CRML
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
$77.1M
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Total Assets
ANDE
ANDE
CRML
CRML
Q4 25
$3.7B
Q3 25
$3.3B
Q2 25
$3.4B
Q1 25
$3.8B
Q4 24
$4.1B
$146.3M
Q3 24
$3.4B
Q2 24
$3.3B
Q1 24
$3.3B
Debt / Equity
ANDE
ANDE
CRML
CRML
Q4 25
0.45×
Q3 25
Q2 25
Q1 25
Q4 24
0.45×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANDE
ANDE
CRML
CRML
Operating Cash FlowLast quarter
$-6.2M
$-2.6M
Free Cash FlowOCF − Capex
$-77.1M
$-2.6M
FCF MarginFCF / Revenue
-23.4%
-719.7%
Capex IntensityCapex / Revenue
21.5%
0.3%
Cash ConversionOCF / Net Profit
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$-56.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANDE
ANDE
CRML
CRML
Q4 25
$-6.2M
Q3 25
$233.9M
Q2 25
$299.3M
Q1 25
$-350.0M
Q4 24
$268.8M
$-2.6M
Q3 24
$-2.1M
Q2 24
$304.4M
Q1 24
$-239.6M
Free Cash Flow
ANDE
ANDE
CRML
CRML
Q4 25
$-77.1M
Q3 25
$167.0M
Q2 25
$250.5M
Q1 25
$-396.6M
Q4 24
$212.9M
$-2.6M
Q3 24
$-40.0M
Q2 24
$275.8M
Q1 24
$-266.4M
FCF Margin
ANDE
ANDE
CRML
CRML
Q4 25
-23.4%
Q3 25
56.5%
Q2 25
46.8%
Q1 25
-106.9%
Q4 24
63.1%
-719.7%
Q3 24
-17.2%
Q2 24
56.0%
Q1 24
-78.0%
Capex Intensity
ANDE
ANDE
CRML
CRML
Q4 25
21.5%
Q3 25
22.6%
Q2 25
9.1%
Q1 25
12.6%
Q4 24
16.6%
0.3%
Q3 24
16.3%
Q2 24
5.8%
Q1 24
7.8%
Cash Conversion
ANDE
ANDE
CRML
CRML
Q4 25
-0.09×
Q3 25
11.61×
Q2 25
38.10×
Q1 25
-1232.46×
Q4 24
5.96×
Q3 24
-0.08×
Q2 24
8.46×
Q1 24
-42.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANDE
ANDE

Specialty And Primary Nutrients$137.1M42%
Premium Ingredients$66.1M20%
Segment Reporting Reconciling Item Other$63.2M19%
Other$63.1M19%

CRML
CRML

Segment breakdown not available.

Related Comparisons